Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2009
03/19/2009WO2009033752A1 Plants which synthesize increased amounts of glucosaminglycans
03/19/2009WO2009033743A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
03/19/2009WO2009033653A1 De novo formation of artificial chromosomes in primary cells and their uses in xenotransplantation, cell and gene therapy
03/19/2009WO2009033536A1 Recombinant preparation of selected bromelain fractions
03/19/2009WO2009033490A1 A method for creating a viral genomic library, a viral genomic library and a kit for creating the same
03/19/2009WO2009033411A1 Method and composition for cancer diagnosis and treatment
03/19/2009WO2009033369A1 Cloning and application of a pleiotropic gene ghd7 that controls grains yield, heading date and plant height of rice
03/19/2009WO2009033293A1 Protein tyrosine phosphatase 1b and cancer
03/19/2009WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
03/19/2009WO2009033276A1 Malva mosaic virus and virus-like particles and uses thereof
03/19/2009WO2009033229A1 Plant seed active transcriptional control sequences
03/19/2009WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
03/19/2009WO2009017673A3 Methods, compositions, and kits for one-step dna cloning using dna topoisomerase
03/19/2009WO2009016212A3 Plants having enhanced yield-related traits and a method for making the same
03/19/2009WO2009013622A3 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
03/19/2009WO2009013448A3 Herpesviruses having altered target cell specificity
03/19/2009WO2009006618A3 Herpes simplex virus mutant icp0 protein
03/19/2009WO2009004068A3 Androgen-dependent 1-f-aromatase reporter gene
03/19/2009WO2008157419A3 Immunogenic peptides of influenza virus
03/19/2009WO2008156551A3 Tat signal peptides for producing proteins in prokaryotes
03/19/2009WO2008154098A3 Reagents and methods for mirna expression analysis and identification of cancer biomarkers
03/19/2009WO2008153366A3 Method for manufacturing active recombinant blood coagulation factor ix
03/19/2009WO2008150495A3 Vwf aptamer formulations and methods for use
03/19/2009WO2008143979A3 Tumor suppressor gene screening using rna interference libraries and method of treatment
03/19/2009WO2008143954A3 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
03/19/2009WO2008134372A3 Production of proanthocyanidins to improve forage quality
03/19/2009WO2008133663A3 Codon modified immunogenic compositions and methods of use
03/19/2009WO2008132485A3 Mutants of interleukin- 1 receptor antagonist and uses thereof
03/19/2009WO2008131419A3 Glycoconjugates of rna interference agents
03/19/2009WO2008118592A3 Use of an avirulent bordetella mutant as a live vaccine vector
03/19/2009WO2008118377A3 Enhanced amylase production by n-terminal addition to mature amylase protein
03/19/2009WO2008114020A3 Mutant g-protein coupled receptors and methods for selecting them
03/19/2009WO2008110325A3 Probiotic
03/19/2009WO2008109470A9 Nucleic acid compounds for inhibiting ptpn1 gene expression and uses thereof
03/19/2009WO2008109142A3 Pirna and uses related thereto
03/19/2009WO2008109105A3 Methods and compositions for improved therapeutic effects with sirna
03/19/2009WO2008100545A3 Production of arachidonic acid in oilseed plants
03/19/2009WO2008079539A3 Recombinant herpesvirus with diminished latency and methods of using same
03/19/2009WO2008070579A3 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
03/19/2009WO2008053018A3 Improved production of secreted proteins by filamentous fungi
03/19/2009WO2007029200A9 Ssb - polymerase fusion proteins
03/19/2009WO2005089122A3 Animals with reduced body fat and increased bone density
03/19/2009WO2005069987A3 Amplifying interfering rna (rnai) expression and effects
03/19/2009US20090077695 Interferon Produced In Plastids
03/19/2009US20090077694 Soybean transformation method
03/19/2009US20090077692 Production of gamma linolenic acid by a delta6-desaturase
03/19/2009US20090077691 Root-Preferred Regulatory Elements
03/19/2009US20090077690 Defensin polynucleotides and methods of use
03/19/2009US20090077689 Defensin polynucleotides and methods of use
03/19/2009US20090077688 Crop plants with disease resistance against fungal pathogens such as Colletotrichum graminicola, Diplodia maydis, Fusarium graminearum, and Fusarium moniliforme, or nematodes
03/19/2009US20090077687 Nematode resistant transgenic plants
03/19/2009US20090077685 Nucleic acid molecules and other molecules associated with plants
03/19/2009US20090077684 Compositions and methods for the modification of physiological responses in plants
03/19/2009US20090077683 Watermelon line wnv142-1115
03/19/2009US20090077682 Tomato line fir 128-1018
03/19/2009US20090077681 Methods for Diagnosing and Treating Heart Disease
03/19/2009US20090077679 Gene silencing by systemic rna interference
03/19/2009US20090077678 Transgenic mollusk and method for producing the same
03/19/2009US20090077677 Mammalian grainyhead transcription factors
03/19/2009US20090076250 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality
03/19/2009US20090076248 Plus end-directed microtubule motor required for chromosome congression
03/19/2009US20090076246 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
03/19/2009US20090076245 HIV-1 Subtype Isolate Regulatory/Accessory Genes, and Modification and Derivatives Thereof
03/19/2009US20090076024 Episomal Fusion Gene
03/19/2009US20090075984 Materials and methods relating to protein aggregation in neurodegenerative disease
03/19/2009US20090075929 Ig20 splice variants therapeutics for cancer
03/19/2009US20090075928 G-QUARTET OLIGONUCLEOTIDES THAT TARGET HYPOXIA-INDUCIBLE FACTOR 1-a (HIF1a )
03/19/2009US20090075927 Sweet taste receptors
03/19/2009US20090075925 Methods and Compositions Related to APOBEC-1 Expression
03/19/2009US20090075924 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease
03/19/2009US20090075923 Methods of treatment of renal disease
03/19/2009US20090075921 Bone/joint disease sensitivity gene and use thereof
03/19/2009US20090075900 Therapeutic agent for motor neuron disease
03/19/2009US20090075889 Iren protein, its preparation and use
03/19/2009US20090075880 Albumin Fusion Proteins
03/19/2009US20090075879 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus
03/19/2009US20090075877 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
03/19/2009US20090075876 Altered insulin-like growth factor binding proteins
03/19/2009US20090075874 Methods for construction and screening of libraries of chemokine variants
03/19/2009US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof
03/19/2009US20090075834 Aptamers and methods for their in vitro selection and uses thereof
03/19/2009US20090075830 System for identifying and analyzing expression of are-containing genes
03/19/2009US20090075388 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins
03/19/2009US20090075384 contain alphavirus 5' and alphavirus 3' replication recognition sequences and a nucleotide sequence encoding an alphavirus structural protein; alphavirus replicon particles useful as immunostimulants
03/19/2009US20090075383 Composition and method for efficient delivery of nucleic acids to cells using chitosan
03/19/2009US20090075380 Methods and Compositions To Enhance Efficiency Of Nuclear Transfer/Cloning
03/19/2009US20090075379 Modulation of homologous recombination with single stranded dna binding proteins
03/19/2009US20090075378 Somatic hypermutation systems
03/19/2009US20090075376 METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA
03/19/2009US20090075373 Neural progenitor cells derived from embryonic stem cells
03/19/2009US20090075370 Vectors
03/19/2009US20090075369 Angiostatin Fragments and Method of Use
03/19/2009US20090075368 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
03/19/2009US20090075358 Vectors for transformation of plant cells
03/19/2009US20090075357 Production of recombinant aav virions
03/19/2009US20090075347 Production of Bacterial Strains Cross Reference To Related Applications
03/19/2009US20090075340 Kir-Binding Agents and Methods of Use Thereof
03/19/2009US20090075339 Autophilic antibodies
03/19/2009US20090075338 Dimeric fusion proteins and materials and methods for producing them
03/19/2009US20090075337 Novel protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof
1 ... 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 ... 4023